HRP970234B1 - Cationic virosomes as transfer system for genetic material - Google Patents

Cationic virosomes as transfer system for genetic material

Info

Publication number
HRP970234B1
HRP970234B1 HR970234A HRP970234A HRP970234B1 HR P970234 B1 HRP970234 B1 HR P970234B1 HR 970234 A HR970234 A HR 970234A HR P970234 A HRP970234 A HR P970234A HR P970234 B1 HRP970234 B1 HR P970234B1
Authority
HR
Croatia
Prior art keywords
transfer system
genetic material
cationic virosomes
virosomes
cationic
Prior art date
Application number
HR970234A
Other languages
English (en)
Inventor
Peter Klein
Reinhard Glueck
Ernst Rudolf Waelti
Original Assignee
Nika Health Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nika Health Products Ltd filed Critical Nika Health Products Ltd
Publication of HRP970234A2 publication Critical patent/HRP970234A2/xx
Publication of HRP970234B1 publication Critical patent/HRP970234B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Saccharide Compounds (AREA)
HR970234A 1996-05-08 1997-05-07 Cationic virosomes as transfer system for genetic material HRP970234B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96107282 1996-05-08

Publications (2)

Publication Number Publication Date
HRP970234A2 HRP970234A2 (en) 1998-06-30
HRP970234B1 true HRP970234B1 (en) 2002-04-30

Family

ID=8222763

Family Applications (1)

Application Number Title Priority Date Filing Date
HR970234A HRP970234B1 (en) 1996-05-08 1997-05-07 Cationic virosomes as transfer system for genetic material

Country Status (28)

Country Link
US (1) US6210708B1 (cs)
EP (1) EP0902682A2 (cs)
JP (1) JP2000509404A (cs)
KR (1) KR100536983B1 (cs)
CN (1) CN1271992C (cs)
AR (1) AR007054A1 (cs)
AU (1) AU710170B2 (cs)
BG (1) BG102880A (cs)
BR (1) BR9709224A (cs)
CA (1) CA2253561A1 (cs)
CO (1) CO4600638A1 (cs)
CZ (1) CZ299809B6 (cs)
EA (1) EA003130B1 (cs)
GT (1) GT199700058A (cs)
HR (1) HRP970234B1 (cs)
HU (1) HUP9901790A3 (cs)
ID (1) ID17934A (cs)
NO (1) NO327726B1 (cs)
NZ (1) NZ332666A (cs)
OA (1) OA10916A (cs)
PA (1) PA8429201A1 (cs)
PE (1) PE65198A1 (cs)
PL (1) PL199201B1 (cs)
SK (1) SK152698A3 (cs)
SV (1) SV1997000032A (cs)
TN (1) TNSN97080A1 (cs)
WO (1) WO1997041834A1 (cs)
ZA (1) ZA973885B (cs)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030113347A1 (en) * 1991-05-08 2003-06-19 Schweiz. Serum- & Impfinstitut Bern Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
AU9224398A (en) * 1997-09-08 1999-03-29 Promega Corporation Method of (in vivo) transformation utilizing lipid vehicles
SE513149C2 (sv) * 1997-12-05 2000-07-17 Katarina Edwards Läkemedelsdistributionssystem med tvåstegsmålsökning, till specifika celler eller vävnad och till dess cellkärna
GB9813100D0 (en) * 1998-06-18 1998-08-19 Secr Defence Method of forming liposomes
WO2001026628A1 (en) * 1999-10-08 2001-04-19 Nika Health Products Limited Cationic dosper virosomes
BR0016472A (pt) * 1999-12-17 2002-08-20 Cápsula de ignição indutivamente ativável para sistemas de retenção de ocupantes de assento
EP1252897A4 (en) * 2000-01-21 2003-07-30 Hisamitsu Pharmaceutical Co MEDICINES FOR GENE THERAPY
WO2003010306A1 (en) * 2001-07-23 2003-02-06 Onyx Pharmaceuticals, Inc. Viral mutants that selectively replicate in targeted human cancer cells
KR100411234B1 (ko) * 2001-08-14 2003-12-18 한국과학기술원 올리고뉴클레오티드 혼성화 미셀 및 그의 제조방법
WO2003038103A1 (en) * 2001-10-29 2003-05-08 Atso Raasmaja Method for gene transfection using synergistic combinations of cationic lipids and cationic polymers
US20040028687A1 (en) * 2002-01-15 2004-02-12 Waelti Ernst Rudolf Methods and compositions for the targeted delivery of therapeutic substances to specific cells and tissues
US20040176283A1 (en) * 2002-04-01 2004-09-09 Robinson John A. Methods and compositions for the design of synthetic vaccines
EA008497B1 (ru) * 2002-11-21 2007-06-29 Певион Биотех Лтд. Высокоэффективные способные к слиянию везикулы, способ их получения и фармацевтическая композиция, их содержащая
US20090208478A1 (en) * 2003-10-24 2009-08-20 Gencia Corporation Transducible polypeptides for modifying metabolism
US20090123468A1 (en) 2003-10-24 2009-05-14 Gencia Corporation Transducible polypeptides for modifying metabolism
US8133733B2 (en) 2003-10-24 2012-03-13 Gencia Corporation Nonviral vectors for delivering polynucleotides to target tissues
AU2004297533B2 (en) 2003-10-24 2010-04-29 Gencia Corporation Methods and compositions for delivering polynucleotides
US8507277B2 (en) 2003-10-24 2013-08-13 Gencia Corporation Nonviral vectors for delivering polynucleotides
US8062891B2 (en) 2003-10-24 2011-11-22 Gencia Corporation Nonviral vectors for delivering polynucleotides to plants
DE102004057303A1 (de) * 2004-11-26 2006-06-01 Merck Patent Gmbh Stabile Kristallmodifikationen von DOTAP Chlorid
US20070172520A1 (en) * 2005-11-18 2007-07-26 University Of South Florida Immunotargeting of Nonionic Surfactant Vesicles
EP2839837B1 (en) * 2006-09-15 2019-05-08 Children's Hospital of Eastern Ontario Research Institute Inc. Oncolytic farmington rhabdovirus
KR101242113B1 (ko) * 2010-10-22 2013-03-19 고마바이오텍(주) 유전자 전달용 양이온성 센다이 ｆ／ｈｎ 바이로좀 복합체
WO2013032643A2 (en) * 2011-08-31 2013-03-07 Dicerna Pharmaceuticals, Inc. Lipids capable of conformational change and their use in formulations to deliver therapeutic agents to cells
US20140335117A1 (en) * 2011-10-07 2014-11-13 Skau Aps Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses
CN109789214B (zh) 2016-09-27 2022-06-28 卡姆拉斯公司 包含edta烷基铵盐的混合物和制剂
CN109055432B (zh) * 2018-08-16 2020-10-13 南京科佰生物科技有限公司 慢病毒感染试剂及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4261975A (en) 1979-09-19 1981-04-14 Merck & Co., Inc. Viral liposome particle
US5264618A (en) * 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
PL296382A1 (en) * 1991-02-02 1993-11-02 Nika Health Products Ltd Li Li Artificial membrane beads containing functionally active peptides responsible for fusion as a drug administering system
CA2086831C (en) * 1991-05-08 1999-03-16 Reinhard Gluck Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
AU3614493A (en) 1992-02-04 1993-09-01 Chiron Corporation Non-toxic lipid vaccine formulations
US5631237A (en) 1992-12-22 1997-05-20 Dzau; Victor J. Method for producing in vivo delivery of therapeutic agents via liposomes
WO1995002698A1 (en) * 1993-07-12 1995-01-26 Life Technologies, Inc. Composition and methods for transfecting eukaryotic cells
AU2520595A (en) * 1994-05-31 1995-12-21 Inex Pharmaceuticals Corp. Virosome-mediated intracellular delivery of therapeutic agents
FR2726764B1 (fr) 1994-11-14 1997-01-31 Pasteur Merieux Serums Vacc Adjuvant pour composition vaccinale

Also Published As

Publication number Publication date
CN1225007A (zh) 1999-08-04
NO985137L (no) 1999-01-04
US6210708B1 (en) 2001-04-03
SK152698A3 (en) 1999-05-07
CZ361498A3 (cs) 1999-03-17
PL329853A1 (en) 1999-04-12
PL199201B1 (pl) 2008-08-29
NO327726B1 (no) 2009-09-14
KR20000010780A (ko) 2000-02-25
ZA973885B (en) 1998-11-06
AR007054A1 (es) 1999-10-13
EP0902682A2 (en) 1999-03-24
BR9709224A (pt) 1999-08-10
CN1271992C (zh) 2006-08-30
KR100536983B1 (ko) 2006-06-29
TNSN97080A1 (fr) 2005-03-15
OA10916A (en) 2003-02-21
EA199800992A1 (ru) 1999-06-24
AU2776697A (en) 1997-11-26
ID17934A (id) 1998-02-12
EA003130B1 (ru) 2003-02-27
BG102880A (en) 1999-05-31
PA8429201A1 (es) 2000-05-24
HRP970234A2 (en) 1998-06-30
CA2253561A1 (en) 1997-11-13
JP2000509404A (ja) 2000-07-25
NO985137D0 (no) 1998-11-04
NZ332666A (en) 2000-05-26
WO1997041834A1 (en) 1997-11-13
SV1997000032A (es) 1998-03-27
AU710170B2 (en) 1999-09-16
HUP9901790A3 (en) 2010-11-29
CZ299809B6 (cs) 2008-12-03
PE65198A1 (es) 1998-10-16
GT199700058A (es) 1998-10-29
CO4600638A1 (es) 1998-05-08
HUP9901790A2 (hu) 1999-08-30

Similar Documents

Publication Publication Date Title
HRP970234A2 (en) Cationic virosomes as transfer system for genetic material
GB2322438B (en) Feed system
AU1830200A (en) Cationic liposomes for gene transfer
IL127416A0 (en) Method for enhancing gene transfer
CZ20001713A3 (cs) Způsob výroby citalopramu
EP0997530A4 (en) FACTORS RELATED TO DNA POLYMERASE
ZA988434B (en) New plant genes
IL134059A0 (en) Process for preparing aminoarylacetylenes
EG23935A (en) Process for preparing eprosartin
EG22077A (en) Process for preparing 4-substituted-ih-indole-3 glyoxamides
IL126184A (en) Process for preparing pentafluoropentanol
GB9703957D0 (en) Tempering system
GB9723540D0 (en) Support means
IL132569A0 (en) Processes for preparing benzothiophenes
GB2330510B (en) Plant support
IL133288A (en) Process for preparing 3-isochromanone
GB9706469D0 (en) Genetic method
IL125646A0 (en) Process for preparing n-pyruvyl-l-proline
IL121130A0 (en) Vertical adjusting support system
LT98059A (en) Process for preparing cationic flockulant
GB9700474D0 (en) Support system for horses
GB9709668D0 (en) Safety support for plants
GB9805373D0 (en) Central heating system
TW369803U (en) Modified water-wal temperature system for greenhouses
GB9717913D0 (en) Dna

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20010507

Year of fee payment: 5

B1PR Patent granted
PBON Lapse due to non-payment of renewal fee

Effective date: 20020508